Palliation for suspected unresectable hilar cholangiocarcinoma

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 341-345

  Connor, S ^a   Barron, E ^a   Redhead, D N ^b   Ireland, H ^b   Madhavan, K K ^a   Parks, R W ^a   Garden, O J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cholangiocarcinoma; Outcome; Palliation

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILE DUCT BYPASS; BILE DUCT CARCINOMA; BILIARY PERITONITIS; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHOLANGITIS; CONTROLLED STUDY; DEMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; INOPERABLE CANCER; INTESTINE OBSTRUCTION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PANCREATITIS; PRIORITY JOURNAL; SEPSIS; STENT; TREATMENT OUTCOME;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT READMISSION; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33947638557     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.11.005     Document Type: Article

References (24)

1. Puhalla H., Gruenberger T., Pokorny H., et al. Resection of hilar cholangiocarcinomas: Pivotal prognostic factors and impact of tumour sclerosis. World J Surg 27 (2003) 680-684
2. Jarnagin W.R., Fong Y., De Matteo R.P., et al. Staging resectability and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-519
3. Nordback I.H., Pitt H.A., Coleman J., et al. Unresectable hilar cholangiocarcinoma: Percutaneous versus operative palliation. Surgery 115 (1994) 597-603
4. Guthrie C.M., Banting S.W., Garden O.J., and Carter D.C. Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg 81 (1994) 1639-1641
5. Taschieri A.M., Elli M., Danelli P.G., Cristaldi M., Montecamozzo G., and Porretta T. Third segment cholangiojejunostomy in the treatment of unresectable Klatskin tumours. Hepatogastroenterology 42 (1995) 597-600
6. Kuvshinoff B.W., Armstrong J.G., Fong Y., et al. Palliation of irresectable cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 82 (1995) 1522-1525
7. Schima W., Prokesch R., Osterreicher C., et al. Biliary wallstent endoprothesis in malignant hilar obstruction: long term results with regard to type of obstruction. Clin Radiol 52 (1997) 213-219
8. Inal M., Akgul E., Demiyurek H., and Yagmur O. Percutaneous self expandable uncovered metallic stents in malignant biliary obstruction. Acta Radiol 44 (2003) 139-146
9. Cheng J.L.S., Bruno M.J., Bergman J.J., Rauws E.A., Tytgat G.N., and Huibrestse K. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: Efficacy of self expandable metallic wall stents. Gastrointest Endosc 56 (2002) 33-39
10. Ortner M.E.J., Caca K., Berr F., et al. Successful photodynamic therapy in non-resectable cholangiocarcinoma: A randomised prospective study. Gasteroenterology 125 (2003) 1355-1362
11. Heron D.E., Stein D.E., Eschelman D.J., et al. Cholangiocarcinoma: the impact of tumour location and treatment strategy on outcome. Am J Clin Oncol 26 (2003) 422-428
12. Jarnagin W.R., Burke E., Powers C., Fong Y., and Blumgart L.H. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 175 (1998) 453-460
13. Li H.M., Dou K.F., Sun K., Gao Z.Q., Li K.Z., and Fu Y.C. Palliative surgery for hilar cholangiocarcinoma. Hepatobil Pancr Dis Int 2 (2003) 110-113
14. Bismuth H., Castaing, and Traynor O. Resection or palliation: Priority of surgery in the treatment of hilar cancer. World J Surg 12 (1988) 39-47
15. O'Suilleabhain C.B., and Madhavan K.K. A modification of segment III cholangiojejeunostomy. Am J Surg 187 (2004) 131-133
16. Washburn WK, Lewis D, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130:270-276.
17. Martin R.C.G., Vitale G.C., Reed D.N., Larson G.M., Edwards M.J., and McMaters K.M. Cost comparison of endoscopic stenting vs. surgical treatment for unresectable cholangiocarcinoma. Surg Endosc 16 (2002) 667-670
18. Orii T., Ohkohchi N., Kikuchi H., et al. Tube cholangio-jejunal bypass in unresectable hepatic hilar carcinoma for a better quality of life. Hepatogastroenterology 50 (2003) 530-531
19. Johnson S.R., Kelly B.S., Penington L.J., and Hanto D.W. A Single centre experience with extrahepatic cholangiocarcinomas. Surgery 130 (2001) 584-592
20. Abraham N.S., Barkun J.S., and Barkun A.N. Palliation of malignant biliary obstruction: A prospective trial examining impact of quality of life. Gastrointest Endosc 56 (2002) 835-841
21. Lai E.C.S., Chu K.M., Lo C.Y., Fan S.T., Lo C.M., and Wong J. Choice of palliation for malignant hilar biliary obstruction. Am J Surg 163 (1992) 208-212
22. Kahn S.A., Davidson B.R., Goldin R., et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 suppl VI (2002) vi1-vi9
23. Gerhards M.F., Vos P., van Guilk T.M., Rauws E.A., Bosma A., and Gouma D.J. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 88 (2001) 48-51
24. Shinchi H., Takao S., Nishida H., and Aikou T. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 75 2 (2000) 89-94